Description: In today’s environment of heightened regulation, constrained funding, and lingering skepticism in the wake of high-profile failures such as Theranos, a well-defined regulatory strategy has become more than a compliance requirement; it is a critical business driver. Investors and board members increasingly recognize that the path to market is central not only to operational execution but also to funding decisions and long-term growth.
This session will draw on the presenter’s hands-on experience supporting multiple start-ups that have successfully leveraged clear, credible regulatory strategies to secure millions in investment. Attendees will gain insights into how regulatory planning can be translated into a compelling business roadmap, de-risking innovation in the eyes of investors and accelerating commercialization.
As regulatory considerations take center stage in strategic decision-making, regulatory professionals are beginning to move from the back office to the C-Suite – reshaping their role from “necessary evil” to essential business partner.
Learning Objectives:
Upon completion, participants will be able to analyze how a robust regulatory strategy can mitigate investor concerns and influence funding decisions.
Upon completion, participants will be able to design a business roadmap that incorporates a regulatory strategy to support product development and market access.
Upon completion, participants will be able to evaluate and influence the evolving role of regulatory affairs in organizational leadership and its impact on strategic decision-making.
